Suppr超能文献

大鼠肾上腺皮质癌与人血小板α2 - 肾上腺素能受体的分子比较

Molecular comparison of alpha 2-adrenergic receptors from rat adrenocortical carcinoma and human blood platelet.

作者信息

Jaiswal R K, Marshak D R, Sharma R K

机构信息

Department of Biochemistry, University of Tennessee, Memphis 38163.

出版信息

Mol Cell Biochem. 1989 Mar 16;86(1):41-53. doi: 10.1007/BF00231688.

Abstract

We have previously described a simple two-step purification technique to isolate alpha 2-adrenergic receptors from the rat adrenocortical carcinoma (Jaiswal, R. K. and Sharma, R. K. (1985) Biochem. Biophys. Res. Commun. 130, 58-64). Utilizing this technique we have now achieved approximately 77,000-fold purification to apparent homogeneity of alpha 2-adrenergic receptors from human platelets. We have compared the biochemical characteristics of these receptors with those from the rat, which were purified approximately 40,000-fold to homogeneity. The [125I] receptor proteins from two sources showed: (a) a single radioactive band with a Mr of 64,000 as evidenced by one- and two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE); and (b) a single symmetrical peak with a pI of 4.2 by isoelectric focusing polyacrylamide gel electrophoresis. Both proteins showed typical alpha 2-adrenergic binding characteristics with specific binding activities of 13.85 nmol/mg and 14.17 nmol/mg protein. These values are close to the theoretical binding activity of 15.6 nmol/mg protein for 1 mol of the ligand binding 1 mol of the receptor protein. These results attest to the purity of the receptors, to its Mr of 64,000, and to its acidic nature. However, the peptide maps of the radioiodinated alpha 2-adrenergic receptors from rat adrenocortical carcinoma and human blood platelets reveal some distinct differences which may relate to the differences in the pharmacological specificities between rodent and non-rodent alpha 2-adrenergic receptors.

摘要

我们之前描述过一种简单的两步纯化技术,用于从大鼠肾上腺皮质癌中分离α2-肾上腺素能受体(贾斯瓦尔,R.K.和夏尔马,R.K.(1985年)《生物化学与生物物理研究通讯》130,58 - 64)。利用该技术,我们现已将人血小板中的α2-肾上腺素能受体纯化至表观均一性,纯化倍数约为77,000倍。我们将这些受体的生化特性与大鼠的受体进行了比较,大鼠受体纯化至均一性的倍数约为40,000倍。来自两种来源的[125I]受体蛋白显示:(a)通过一维及二维十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS - PAGE)证明,有一条Mr为64,000的单一放射性条带;(b)通过等电聚焦聚丙烯酰胺凝胶电泳,有一个pI为4.2的单一对称峰。两种蛋白均显示出典型的α2-肾上腺素能结合特性,比活性分别为13.85 nmol/mg和14.17 nmol/mg蛋白。这些值接近1摩尔配体结合1摩尔受体蛋白时15.6 nmol/mg蛋白的理论结合活性。这些结果证明了受体的纯度、其Mr为64,000以及其酸性性质。然而,大鼠肾上腺皮质癌和人血小板的放射性碘化α2-肾上腺素能受体的肽图显示出一些明显差异,这可能与啮齿动物和非啮齿动物α2-肾上腺素能受体在药理学特异性上的差异有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验